Wealth Enhancement Advisory Services LLC cut its position in Clarivate Plc (NYSE:CLVT – Free Report) by 37.3% during the 3rd quarter, HoldingsChannel reports. The firm owned 32,725 shares of the company’s stock after selling 19,504 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Clarivate were worth $232,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors also recently made changes to their positions in the company. Sumitomo Mitsui DS Asset Management Company Ltd lifted its stake in shares of Clarivate by 21.3% in the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 35,841 shares of the company’s stock worth $254,000 after acquiring an additional 6,284 shares during the period. Creative Planning acquired a new stake in Clarivate in the third quarter worth approximately $142,000. Handelsbanken Fonder AB boosted its stake in Clarivate by 18.6% during the 3rd quarter. Handelsbanken Fonder AB now owns 114,100 shares of the company’s stock valued at $810,000 after purchasing an additional 17,900 shares in the last quarter. Sanctuary Advisors LLC acquired a new position in shares of Clarivate during the 2nd quarter valued at $258,000. Finally, Truist Financial Corp bought a new stake in shares of Clarivate in the 2nd quarter worth $63,000. Institutional investors and hedge funds own 85.72% of the company’s stock.
Clarivate Stock Performance
Shares of CLVT opened at $4.59 on Tuesday. The company’s 50 day moving average price is $6.51 and its 200 day moving average price is $6.25. The company has a debt-to-equity ratio of 0.84, a quick ratio of 0.90 and a current ratio of 0.88. Clarivate Plc has a 52 week low of $4.43 and a 52 week high of $9.60. The company has a market capitalization of $3.26 billion, a PE ratio of -2.31 and a beta of 1.18.
Insider Activity at Clarivate
In related news, Director Saurabh Saha sold 17,646 shares of the company’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $6.75, for a total value of $119,110.50. Following the completion of the sale, the director now directly owns 23,741 shares in the company, valued at approximately $160,251.75. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In related news, Director Saurabh Saha sold 17,646 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $6.75, for a total value of $119,110.50. Following the completion of the sale, the director now directly owns 23,741 shares in the company, valued at approximately $160,251.75. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Bar Veinstein sold 60,000 shares of the stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $7.00, for a total value of $420,000.00. Following the transaction, the insider now owns 916,583 shares in the company, valued at approximately $6,416,081. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 197,646 shares of company stock valued at $1,379,111. 22.77% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
CLVT has been the subject of several research reports. Royal Bank of Canada reduced their price objective on shares of Clarivate from $7.00 to $6.00 and set a “sector perform” rating for the company in a research report on Thursday, November 7th. William Blair lowered shares of Clarivate from an “outperform” rating to a “market perform” rating in a research note on Wednesday, November 6th. Finally, Barclays decreased their price target on shares of Clarivate from $5.00 to $4.00 and set an “underweight” rating on the stock in a research report on Thursday, November 7th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $7.25.
Get Our Latest Report on Clarivate
Clarivate Profile
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Further Reading
- Five stocks we like better than Clarivate
- Trading Halts Explained
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- 3 Fintech Stocks With Good 2021 Prospects
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Want to see what other hedge funds are holding CLVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clarivate Plc (NYSE:CLVT – Free Report).
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.